Senti Biosciences Holdings, Inc. (SNTI) stock
SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.04 (-28.68%)
Close on Nov 17, 2026Market cap $3.02MP/E –Yield –
Senti Biosciences total assets
Total assets on the balance sheet at the end of each period.
Senti Biosciences's total assets was $33.11M at Jun 30, 2026. For fiscal 2025 it was $51.22M, down 47.6% from the year before. The highest annual figure on record is $180.79M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.22M | -47.6% |
| FY2024 | Dec 31, 2024 | $97.84M | -18.1% |
| FY2023 | Dec 31, 2023 | $119.48M | -33.9% |
| FY2022 | Dec 31, 2022 | $180.79M | +87.0% |
| FY2021 | Dec 31, 2021 | $96.70M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.11M | -51.7% |
| Q1 FY2026 | Mar 31, 2026 | $38.24M | -53.8% |
| Q4 FY2025 | Dec 31, 2025 | $51.22M | -47.6% |
| Q3 FY2025 | Sep 30, 2025 | $52.69M | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $68.54M | -21.1% |
| Q1 FY2025 | Mar 31, 2025 | $82.78M | -19.0% |
| Q4 FY2024 | Dec 31, 2024 | $97.84M | -18.1% |
| Q3 FY2024 | Sep 30, 2024 | $57.72M | -56.2% |
| Q2 FY2024 | Jun 30, 2024 | $86.91M | -39.5% |
| Q1 FY2024 | Mar 31, 2024 | $102.19M | -36.7% |
| Q4 FY2023 | Dec 31, 2023 | $119.48M | -33.9% |
| Q3 FY2023 | Sep 30, 2023 | $131.77M | -30.4% |
| Q2 FY2023 | Jun 30, 2023 | $143.63M | -29.0% |
| Q1 FY2023 | Mar 31, 2023 | $161.43M | -30.1% |
| Q4 FY2022 | Dec 31, 2022 | $180.79M | +87.0% |
| Q3 FY2022 | Sep 30, 2022 | $189.44M | -18.2% |
| Q2 FY2022 | Jun 30, 2022 | $202.36M | -12.7% |
| Q1 FY2022 | Mar 31, 2022 | $230.92M | +61698.9% |
| Q4 FY2021 | Dec 31, 2021 | $96.70M | – |
| Q3 FY2021 | Sep 30, 2021 | $231.66M | – |
| Q2 FY2021 | Jun 30, 2021 | $231.89M | – |
| Q1 FY2021 | Mar 31, 2021 | $373.66K | – |
See a number that looks wrong?